Ozempic, Wegovy and other new drugs are selected for Medicare’s price negotiations
By AMANDA SEITZ
WASHINGTON (AP) — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said Friday.
The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration and almost assures billions of dollars in savings for taxpayers.
Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey.
More Stories
Ofcom orders Openreach to withdraw £9.50 full-fibre discount
Ofcom has today directed Openreach to withdraw a wholesale offer that would have given internet service providers a discount of...
Police refuse to reopen RBS hotel loan case without judicial review
Police Scotland has closed its handling of fraud allegations made by an Edinburgh businessman against Royal Bank of Scotland, telling...
Mustafa Suleyman warns AI has reached a “watershed moment”
Mustafa Suleyman, chief executive of Microsoft AI, has said artificial intelligence has reached a “watershed moment”, pointing to agents that...
Insolvency Service puts phoenixing directors at top of new strategy
The Insolvency Service will make abusive phoenixing, where directors repeatedly walk away from company debts and set up similar businesses...
John Lewis adds art galleries and 12 travel hubs to its stores
The John Lewis Partnership is expanding its concessions into fine art and bespoke travel, adding three art galleries and 12...
George Bamford to become JCB joint chairman as profits slip to £642m
George Bamford will become joint chairman of JCB alongside his father, Lord Bamford, on 1 October, the first change at...